Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above.
Condition: Herpes Zoster Interventions: Biological: Low Dose Recombinant Herpes Zoster Vaccine (CHO cells); Biological: High Dose Recombinant Herpes Zoster Vaccine (CHO cells); Biological: Low dose adjuvant; Biological: High dose adjuvant; Biological: Positive control; Biological: Placebo Sponsors: MAXVAX Biotechnology Limited Liability Company; Henan Center for Disease Control and Prevention Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2022 Category: Research Source Type: clinical trials
Herpes Virus Infections in Kidney Transplant Patients
Conditions: Kidney Transplant; Complications; Varicella Zoster Virus Infection; Vaccine-Preventable Diseases Intervention: Sponsors: Susanne Dam Nielsen, MD, DMSc; Technical University of Denmark; Aarhus University Hospital; Odense University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2022 Category: Research Source Type: clinical trials
